How should we structure an exclusive global licensing agreement for our patented medical device to ensure we maintain strict quality control without triggering antitrust issues?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
How should we structure an exclusive global licensing agreement for our patented medical device to ensure we maintain strict quality control without triggering antitrust issues?
3 real searches · 1 real-search pass
2026 current antitrust intellectual property licensing guidelines United States DOJ FTC withdrawn 2024 officialGoogle ↗
OBSERVEDReason
European Commission technology transfer block exemption regulation 2026 licensing competition rules officialGoogle ↗
OBSERVEDReason
FDA Quality Management System Regulation effective February 2 2026 medical devices officialGoogle ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
2026 current antitrust intellectual property licensing guidelines United States DOJ FTC withdrawn 2024 official Google ↗
European Commission technology transfer block exemption regulation 2026 licensing competition rules official Google ↗
FDA Quality Management System Regulation effective February 2 2026 medical devices official Google ↗
- Quality and Compliance (Medical Devices) · fda.gov
- Quality Management System Regulation – Frequently Asked Questions · fda.gov
- Antitrust Division | 2017 Update of the Antitrust Guidelines for the Licensing of Intellectual Property · justice.gov
- FTC and DOJ Issue Updated Antitrust Guidelines for the Licensing of Intellectual Property · ftc.gov
- TTBER · competition-policy.ec.europa.eu
- Regulation - EU - 2026/877 - EN · eur-lex.europa.eu
- Regulation - EU - 2026/877 - EN · eur-lex.europa.eu
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 current antitrust intellectual property licensing guidelines United States DOJ FTC withdrawn 2024 official OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
European Commission technology transfer block exemption regulation 2026 licensing competition rules official OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
FDA Quality Management System Regulation effective February 2 2026 medical devices official OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 |